• Binnicker MJ, Jespersen DJ, Bestrom JE & Rollins LO (2012) Comparison of four assays for the detection of cryptococcal antigen. Clinical and Vaccine Immunology 19, 19881990.
  • Gates-Hollingsworth MA & Kozel TR (2013) Serotype sensitivity of a lateral flow immunoassay for cryptococcal antigen (CrAg). Clinical and Vaccine Immunology 20, 634635.
  • Hansen J, Slechta ES, Gates-Hollingsworth MA et al. (2013) Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid. Clinical and Vaccine Immunology 20, 5255.
  • Jarvis JN & Harrison TS (2007) HIV-associated cryptococcal meningitis. AIDS 21, 21192129.
  • Jarvis JN, Lawn SD, Vogt M, Bangani N, Wood R & Harrison TS (2009) Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clinical Infectious Diseases 48, 856862.
  • Jarvis JN, Lawn SD, Wood R & Harrison TS (2010) Cryptococcal antigen screening for patients initiating antiretroviral therapy: time for action. Clinical Infectious Diseases 51, 14631465.
  • Jarvis JN, Percival A, Bauman S et al. (2011) Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clinical Infectious Diseases 53, 10191023.
  • Jarvis JN, Govender N, Chiller T et al. (2012) Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation. Journal of the International Association of Physicians in AIDS Care 11, 374379.
  • Jarvis JN, Harrison TS, Lawn SD, Meintjes G, Wood R & Cleary S (2013) Cost effectiveness of cryptococcal antigen screening as a strategy to prevent hiv-associated cryptococcal meningitis in South Africa. PLoS ONE 8, e69288.
  • Kisenge PR, Hawkins AT, Maro VP et al. (2007) Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania. BMC Infectious Diseases 14, 39.
  • Kwan CK, Leelawiwat W, Intalapaporn P et al. (2012) Utility of cryptococcal antigen screening and evolution of asymptomatic cryptococcal antigenaemia among HIV-infected women starting antiretroviral therapy in Thailand. 19th Conference on Retroviruses and Opportunistic Infections (CROI). Seattle, WA.
  • Lara-Peredo O, Cuevas LE, French N, Bailey JW & Smith DH (2000) Cryptococcal infection in an HIV-positive Ugandan population. Journal of Infection 41, 195.
  • Lawn SD, Harries AD, Anglaret X, Myer L & Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22, 18971908.
  • Liechty CA, Solberg P, Were W et al. (2007) Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Tropical Medicine & International Health: TM & IH 12, 929935.
  • Lindsley MD, Mekha N, Baggett HC et al. (2011) Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clinical Infectious Diseases 53, 321325.
  • McMullan BJ, Halliday C, Sorrell TC et al. (2012) Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory. PLoS ONE 7, e49541.
  • Meya DB, Manabe YC, Castelnuovo B et al. (2010) Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings. Clinical Infectious Diseases 51, 448455.
  • Meyer AC, Kendi CK, Penner JA et al. (2013) The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in Kenya. Tropical Medicine & International Health: TM & IH 18, 495503.
  • NHLS (2013) Laboratory-based screening for cryptococcal disease. Report for the period: 3 September - 21 December 2012. National Institute for Communicable Diseases; (accessed 27 Feb 2013).
  • Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG & Chiller TM (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23, 525530.
  • Tassie JM, Pepper L, Fogg C et al. (2003) Systematic screening of cryptococcal antigenemia in HIV-positive adults in Uganda. Journal of Acquired Immune Deficiency Syndromes 33, 411412.
  • Wajanga BM, Kalluvya S, Downs JA, Johnson WD, Fitzgerald DW & Peck RN (2011) Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study. Journal of the International AIDS Society 11, 48.
  • Walker AS, Prendergast AJ, Mugyenyi P et al. (2012) Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe. Clinical Infectious Diseases 55, 17071718.